Your browser doesn't support javascript.
loading
Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
Clarke, Megan A; Wentzensen, Nicolas; Perkins, Rebecca B; Garcia, Francisco; Arrindell, Deborah; Chelmow, David; Cheung, Li C; Darragh, Teresa M; Egemen, Didem; Guido, Richard; Huh, Warner; Locke, Alexander; Lorey, Thomas S; Nayar, Ritu; Risley, Carolann; Saslow, Debbie; Smith, Robert A; Unger, Elizabeth R; Massad, L Stewart.
Afiliação
  • Clarke MA; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.
  • Wentzensen N; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.
  • Perkins RB; Department of Obstetrics and Gynecology, Boston University School of Medicine/Boston Medical Center, Boston, MA.
  • Garcia F; Pima County Administration, Tucson, AZ.
  • Arrindell D; American Sexual Health Association, Washington, DC.
  • Chelmow D; Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, VA.
  • Cheung LC; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.
  • Darragh TM; The Department of Pathology, University of California, San Francisco, CA.
  • Egemen D; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.
  • Guido R; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Magee-Womens Hospital, Pittsburgh, PA.
  • Huh W; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.
  • Locke A; Department of Obstetrics and Gynecology (Retired), The Permanente Medical Group, Oakland, CA.
  • Lorey TS; Regional Laboratory, Kaiser Permanente Northern California, Oakland, CA.
  • Nayar R; Department of Pathology, Northwestern University Feinberg School of Medicine and Northwestern Medical Group, Chicago, IL.
  • Saslow D; Prevention and Early Detection Department, American Cancer Society, Atlanta, GA.
  • Smith RA; Early Cancer Detection Science, American Cancer Society, Atlanta, GA.
  • Unger ER; Chronic Viral Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA.
  • Massad LS; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO.
J Low Genit Tract Dis ; 28(2): 124-130, 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-38446575
ABSTRACT

OBJECTIVES:

The Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee developed recommendations for dual stain (DS) testing with CINtec PLUS Cytology for use of DS to triage high-risk human papillomavirus (HPV)-positive results.

METHODS:

Risks of cervical intraepithelial neoplasia grade 3 or worse were calculated according to DS results among individuals testing HPV-positive using data from the Kaiser Permanente Northern California cohort and the STudying Risk to Improve DisparitiES study in Mississippi. Management recommendations were based on clinical action thresholds developed for the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines. Resource usage metrics were calculated to support decision-making. Risk estimates in relation to clinical action thresholds were reviewed and used as the basis for draft recommendations. After an open comment period, recommendations were finalized and ratified through a vote by the Consensus Stakeholder Group.

RESULTS:

For triage of positive HPV results from screening with primary HPV testing (with or without genotyping) or with cytology cotesting, colposcopy is recommended for individuals testing DS-positive. One-year follow-up with HPV-based testing is recommended for individuals testing DS-negative, except for HPV16- and HPV18-positive results, or high-grade cytology in cotesting, where immediate colposcopy referral is recommended. Risk estimates were similar between the Kaiser Permanente Northern California and STudying Risk to Improve DisparitiES populations. In general, resource usage metrics suggest that compared with cytology, DS requires fewer colposcopies and detects cervical intraepithelial neoplasia grade 3 or worse earlier.

CONCLUSIONS:

Dual stain testing with CINtec PLUS Cytology is acceptable for triage of HPV-positive test results. Risk estimates are portable across different populations.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Displasia do Colo do Útero / Neoplasias do Colo do Útero / Infecções por Papillomavirus Limite: Female / Humans / Pregnancy Idioma: En Revista: J Low Genit Tract Dis Assunto da revista: GINECOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Moldávia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Displasia do Colo do Útero / Neoplasias do Colo do Útero / Infecções por Papillomavirus Limite: Female / Humans / Pregnancy Idioma: En Revista: J Low Genit Tract Dis Assunto da revista: GINECOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Moldávia